The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation
Open accessAbstract
The Ewing sarcoma family of tumors (EFT) is a group of highly malignant small round blue cell tumors occurring in children and young adults. We report here the largest genomic survey to date of 101 EFT (65 tumors and 36 cell lines). Using a combination of whole genome sequencing and targeted sequencing approaches, we discover that EFT has a very low mutational burden (0.15 mutations/Mb) but frequent deleterious mutations in the cohesin complex subunit STAG2 (21.5% tumors, 44.4% cell lines), homozygous deletion of CDKN2A (13.8% and 50%) and mutations of TP53 (6.2% and 71.9%). We additionally note an increased prevalence of the BRCA2 K3326X polymorphism in EFT patient samples (7.3%) compared to population data (OR 7.1, p = 0.006). Using whole transcriptome sequencing, we find that 11% of tumors pathologically diagnosed as EFT lack a typical EWSR1 fusion oncogene and that these tumors do not have a characteristic Ewing sarcoma gene expression signature. We identify samples harboring novel fusion genes including FUS-NCATc2 and CIC-FOXO4 that may represent distinct small round blue cell tumor variants. In an independent EFT tissue microarray cohort, we show that STAG2 loss as detected by immunohistochemistry may be associated with more advanced disease (p = 0.15) and a modest decrease in overall survival (p = 0.10). These results significantly advance our understanding of the genomic and molecular underpinnings of Ewing sarcoma and provide a foundation towards further efforts to improve diagnosis, prognosis, and precision therapeutics testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,621
Circos: An information aesthetic for comparative genomics
Krzywinski, M., Schein, J., Birol, İ., Connors, J., Gascoyne, R., Horsman, D., Jones, S. J., & Marra, M. A. (2009) · Genome Research · doi:10.1101/gr.092759.109 · Cited by 10,964
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
Systematic identification of genomic markers of drug sensitivity in cancer cells
Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456
Self-citationHuman Genome Sequencing Using Unchained Base Reads on Self-Assembling DNA Nanoarrays
Drmanac, R., Sparks, A. B., Callow, M. J., Halpern, A. L., Burns, N. L., Kermani, B. G., Carnevali, P., Nazarenko, I., Nilsen, G. B., Yeung, G., et al. (2010) · Science · doi:10.1126/science.1181498 · Cited by 1,212 · cited 1×
“0 [57], ANNOVAR v2012-05-25 [58], and Circos v0.”
Self-citationDelattre, O., Zucman, J., Melot, T., Garau, X. S., Zucker, J.-M., Lenoir, G. M., Ambros, P. F., Sheer, D., Turc-Carel, C., Triche, T. J., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408043310503 · Cited by 1,107
Self-citationDiverse somatic mutation patterns and pathway alterations in human cancers
Kan, Z., Jaiswal, B. S., Stinson, J., Janakiraman, V., Bhatt, D., Stern, H. M., Yue, P., Haverty, P. M., Bourgon, R., Zheng, J., et al. (2010) · Nature · doi:10.1038/nature09208 · Cited by 1,027
Skálová, A., Vanecek, T., Sima, R., Laco, J., Weinreb, I., Perez-Ordonez, B., Starek, I., Geierova, M., Simpson, R. H., Passador-Santos, F., et al. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181d9efcc · Cited by 1,023
Plon, S. E., Eccles, D. M., Easton, D., Foulkes, W. D., Genuardi, M., Greenblatt, M. S., Hogervorst, F. B. L., Hoogerbrugge, N., Spurdle, A. B., Tavtigian, S. V., et al. (2008) · Human Mutation · doi:10.1002/humu.20880 · Cited by 912
Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma
Tognon, C., Knezevich, S. R., Huntsman, D., Roskelley, C. D., Melnyk, N., Mathers, J. A., Becker, L., Carneiro, F., MacPherson, N., Horsman, D., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00180-0 · Cited by 911
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
Molenaar, J. J., Koster, J., Zwijnenburg, D. A., van Sluis, P., Valentijn, L. J., van der Ploeg, I., Hamdi, M., van Nes, J., Westerman, B. A., van Arkel, J., et al. (2012) · Nature · doi:10.1038/nature10910 · Cited by 870
TopHat-Fusion: an algorithm for discovery of novel fusion transcripts
Kim, D., & Salzberg, S. L. (2011) · Genome Biology · doi:10.1186/gb-2011-12-8-r72 · Cited by 809
A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma
Knezevich, S. R., McFadden, D. E., Tao, W., Lim, J. F., & Sorensen, P. H. B. (1998) · Nature Genetics · doi:10.1038/ng0298-184 · Cited by 800
Shern, J. F., Chen, L., Chmielecki, J., Wei, J. S., Patidar, R., Rosenberg, M., Ambrogio, L., Auclair, D., Wang, J., Song, Y. K., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0639 · Cited by 756
Self-citationEsiashvili, N., Goodman, M., & Marcus, R. B. (2008) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e31816e22f3 · Cited by 582
deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data
McPherson, A., Hormozdiari, F., Zayed, A., Giuliany, R., Ha, G., Sun, M. G. F., Griffith, M., Heravi Moussavi, A., Senz, J., Melnyk, N., et al. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1001138 · Cited by 557
A novel retinoblastoma therapy from genomic and epigenetic analyses
Zhang, J., Benavente, C. A., McEvoy, J., Flores-Otero, J., Ding, L., Chen, X., Ulyanov, A., Wu, G., Wilson, M., Wang, J., et al. (2012) · Nature · doi:10.1038/nature10733 · Cited by 516
Self-citationGuo, G., Sun, X., Chen, C., Wu, S., Huang, P., Li, Z., Dean, M., Huang, Y., Jia, W., Zhou, Q., et al. (2013) · Nature Genetics · doi:10.1038/ng.2798 · Cited by 482
Self-citationTurc-Carel, C., Aurias, A., Mugneret, F., Lizard, S., Sidaner, I., Volk, C., Thiery, J. P., Olschwang, S., Philip, I., Berger, M. P., et al. (1988) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(88)90285-3 · Cited by 466
Congenital Mesoblastic Nephroma t(12;15) Is Associated withETV6-NTRK3 Gene Fusion
Rubin, B. P., Chen, C.-J., Morgan, T. W., Xiao, S., Grier, H. E., Kozakewich, H. P., Perez-Atayde, A. R., & Fletcher, J. A. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65732-x · Cited by 437
Mutational Inactivation of STAG2 Causes Aneuploidy in Human Cancer
Solomon, D. A., Kim, T., Diaz-Martinez, L. A., Fair, J., Elkahloun, A. G., Harris, B. T., Toretsky, J. A., Rosenberg, S. A., Shukla, N., Ladanyi, M., et al. (2011) · Science · doi:10.1126/science.1203619 · Cited by 436
Self-citationA remarkably simple genome underlies highly malignant pediatric rhabdoid cancers
Lee, R. S., Stewart, C., Carter, S. L., Ambrogio, L., Cibulskis, K., Sougnez, C., Lawrence, M. S., Auclair, D., Mora, J., Golub, T. R., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64400 · Cited by 428
Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms
Kon, A., Shih, L.-Y., Minamino, M., Sanada, M., Shiraishi, Y., Nagata, Y., Yoshida, K., Okuno, Y., Bando, M., Nakato, R., et al. (2013) · Nature Genetics · doi:10.1038/ng.2731 · Cited by 384
Italiano, A., Sung, Y., Zhang, L., Singer, S., Maki, R. G., Coindre, J., & Antonescu, C. R. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20945 · Cited by 364
Targeting Oxidative Stress in Embryonal Rhabdomyosarcoma
Chen, X., Stewart, E., Shelat, A. A., Qu, C., Bahrami, A., Hatley, M., Wu, G., Bradley, C., McEvoy, J., Pappo, A., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.11.002 · Cited by 294
Self-citationClonal diversity of recurrently mutated genes in myelodysplastic syndromes
Walter, M. J., Shen, D., Shao, J., Ding, L., White, B. S., Kandoth, C., Miller, C. A., Niu, B., McLellan, M. D., Dees, N. D., et al. (2013) · Leukemia · doi:10.1038/leu.2013.58 · Cited by 284
Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy
Balbás-Martínez, C., Sagrera, A., Carrillo-de-Santa-Pau, E., Earl, J., Márquez, M., Vazquez, M., Lapi, E., Castro-Giner, F., Beltran, S., Bayés, M., et al. (2013) · Nature Genetics · doi:10.1038/ng.2799 · Cited by 273
Promiscuous partnerships in Ewing's sarcoma
Sankar, S., & Lessnick, S. L. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.07.008 · Cited by 258
ETV6‐NTRK3 is a common chromosomal rearrangement in radiation‐associated thyroid cancer
Leeman‐Neill, R. J., Kelly, L. M., Liu, P., Brenner, A. V., Little, M. P., Bogdanova, T. I., Evdokimova, V. N., Hatch, M., Zurnadzy, L. Y., Nikiforova, M. N., et al. (2014) · Cancer · doi:10.1002/cncr.28484 · Cited by 257
Huang, H.-Y., Illei, P. B., Zhao, Z., Mazumdar, M., Huvos, A. G., Healey, J. H., Wexler, L. H., Gorlick, R., Meyers, P., & Ladanyi, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.081 · Cited by 248
Borkhardt, A., Repp, R., Haas, O. A., Leis, T., Harbott, J., Kreuder, J., Hammermann, J., Henn, T., & Lampert, F. (1997) · Oncogene · doi:10.1038/sj.onc.1200814 · Cited by 238
Survival After Recurrence of Ewing’s Sarcoma Family of Tumors
Barker, L. M., Pendergrass, T. W., Sanders, J. E., & Hawkins, D. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.105 · Cited by 219
Frequent truncating mutations of STAG2 in bladder cancer
Solomon, D. A., Kim, J.-S., Bondaruk, J., Shariat, S. F., Wang, Z.-F., Elkahloun, A. G., Ozawa, T., Gerard, J., Zhuang, D., Zhang, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2800 · Cited by 208
Self-citationSzuhai, K., IJszenga, M., de Jong, D., Karseladze, A., Tanke, H. J., & Hogendoorn, P. C. W. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2184 · Cited by 204
Tsuchiya, T., Sekine, K.-I., Hinohara, S.-I., Namiki, T., Nobori, T., & Kaneko, Y. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00255-1 · Cited by 179
A polymorphic stop codon in BRCA2
Mazoyer, S., Dunning, A. M., Serova, O., Dearden, J., Puget, N., Healey, C. S., Gayther, S. A., Mangion, J., Stratton, M. R., Lynch, H. T., et al. (1996) · Nature Genetics · doi:10.1038/ng1196-253 · Cited by 174
Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions.
Barr, F. G., Qualman, S. J., Macris, M. H., Melnyk, N., Lawlor, E. R., Strzelecki, D. M., Triche, T. J., Bridge, J. A., & Sorensen, P. H. B. (2002) · PubMed · Cited by 172
Self-citationHasselblatt, M., Isken, S., Linge, A., Eikmeier, K., Jeibmann, A., Oyen, F., Nagel, I., Richter, J., Bartelheim, K., Kordes, U., et al. (2012) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22018 · Cited by 158
Kovar, H., Jug, G., Aryee, D. N. T., Zoubek, A., Ambros, P. F., Gruber, B., Windhager, R. H., & Gadner, H. (1997) · Oncogene · doi:10.1038/sj.onc.1201397 · Cited by 149
Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas.
Komuro, H., Hayashi, Y., Kawamura, M., Hayashi, K., Kaneko, Y., Kamoshita, S., Hanada, R., Yamamoto, K., Hongo, T., & Yamada, M. (1993) · PubMed · Cited by 135
Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization
Armengol, G., Tarkkanen, M., Virolainen, M. J., Forus, A., Valle, J., Böhling, T., Asko-Seljavaara, S. L., BLOMQVIST, C. P., Elomaa, I., Karaharju, E., et al. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.242 · Cited by 122
Variants in theGH-IGFaxis confer susceptibilityto lung cancerPreprint
Rudd, M. F., Webb, E. L., Matakidou, A., Sellick, G. S., Williams, R. D., Bridle, H. L., Eisen, T. G., & Houlston, R. S. (2006) · Genome Research · doi:10.1101/gr.5120106 · Cited by 121
Bauerschmidt, C., Arrichiello, C., Burdak‐Rothkamm, S., Woodcock, M., Hill, M. A., Stevens, D. L., & Rothkamm, K. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp976 · Cited by 119
Narrow spectrum of infrequent p53 mutations and absence of MDM2 amplification in Ewing tumours.
Kovar, H., Auinger, A., Jug, G., et al. (1993) · PubMed · Cited by 113
Prognostic impact of INK4A deletion in Ewing sarcoma
Guo, W., Antonescu, C. R., de Álava, E., Leung, D. H. Y., Huvos, A. G., Meyers, P. A., Healey, J. H., & Ladanyi, M. (2000) · Cancer · Cited by 111
Identification of Rad51 alteration in patients with bilateral breast cancer
Kato, M., Yano, K., Matsuo, F., Saito, H., Katagiri, T., Kurumizaka, H., Yoshimoto, M., Kasumi, F., Akiyama, F., Sakamoto, G., et al. (2000) · Journal of Human Genetics · doi:10.1007/s100380050199 · Cited by 110
Molecular Analysis of the 9p21 Locus and p53 Genes in Ewing Family Tumors
López‐Guerrero, J. A., Pellín, A., Noguera, R., Cardá, C., & Llombart‐Bosch, A. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780290 · Cited by 89
Self-citationMartin, S., Matsubayashi, H., Rogers, C. D., Philips, J., Couch, F. J., Brune, K. A., Yeo, C. J., Kern, S. E., Hruban, R. H., & Goggins, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208411 · Cited by 87
Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma
Akbari, M. R., Malekzadeh, R., Nasrollahzadeh, D., Amanian, D., Islami, F., Li, S., Zandvakili, I., Shakeri, R., Sotoudeh, M., Aghcheli, K., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210739 · Cited by 83
Synthetic Lethality of Cohesins with PARPs and Replication Fork Mediators
McLellan, J. L., O’Neil, N. J., Barrett, I. J., Ferree, E. J., van Pel, D. M., Ushey, K., Sipahimalani, P., Bryan, J., Rose, A. M., & Hieter, P. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002574 · Cited by 83
Savola, S. P., Arto Klami, A., Tripathi, A., Niini, T., Serra, M., Picci, P., Samuel Kaski, A., Zambelli, D., Scotlandi, K., & Knuutila, S. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-17 · Cited by 76
Self-citationDiagnosis of the Small Round Blue Cell Tumors Using Multiplex Polymerase Chain Reaction
Chen, Q., Vansant, G., Oades, K., Pickering, M., Wei, J. S., Song, Y., Monforte, J., & Khan, J. I. (2007) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2007.060111 · Cited by 58
Self-citationLópez‐Guerrero, J. A., Machado, I., Scotlandi, K., Noguera, R., Pellı́n, A., Navarro, S., Serra, M., Fariñas, S. C., Picci, P., & Llombart‐Bosch, A. (2010) · International Journal of Cancer · doi:10.1002/ijc.25424 · Cited by 56
Self-citationp53 mutations in human tumors with chimeric EWS/FLI/1 genes
Hamelin, R., Zucman‐Rossi, J., Melot, T., Delatre, O., & Thomas, G. D. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570308 · Cited by 52
Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT
Brownhill, S. C., Taylor, C., & Burchill, S. A. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603819 · Cited by 42
Kim, M. S., An, C. H., Yoo, N. J., & Lee, S. H. (2013) · Human Pathology · doi:10.1016/j.humpath.2013.04.017 · Cited by 28
Cuadrado, A., Remeseiro, S., Goméz-López, G., Pisano, D. G., & Losada, A. (2012) · Cell Cycle · doi:10.4161/cc.20318 · Cited by 24
Cited by
Whole-genome landscape of pancreatic neuroendocrine tumours
Initiative, A. P. C. G., Scarpa, A., Chang, D. K., Nones, K., Corbo, V., Patch, A.-M., Bailey, P., Lawlor, R. T., Johns, A. L., Miller, D. K., et al. (2017) · Nature · doi:10.1038/nature21063 · Cited by 999
Grünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0003-x · Cited by 873
The Genomic Landscape of Pediatric Ewing Sarcoma
Crompton, B. D., Stewart, C., Taylor-Weiner, A., Alexe, G., Kurek, K. C., Calicchio, M. L., Kiezun, A., Carter, S. L., Shukla, S. A., Mehta, S. S., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-1037 · Cited by 566
Tirode, F., Surdez, D., Ma, X., Parker, M., Le Deley, M. C., Bahrami, A., Zhang, Z., Lapouble, E., Grossetête-Lalami, S., Rusch, M., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0622 · Cited by 565
Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain
Boulay, G., Sandoval, G. J., Riggi, N., Iyer, S., Buisson, R., Naigles, B., Awad, M. E., Rengarajan, S., Volorio, A., McBride, M. J., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.036 · Cited by 470
Metadata
- Authors
- Brohl, A. S., Solomon, D. A., Chang, W., Wang, J., Song, Y., Sindiri, S., Patidar, R., Hurd, L., Chen, L., Shern, J. F., Liao, H., Wen, X., Gerard, J., Kim, J.-S., Lopez Guerrero, J. A., Machado, I., Wai, D. H., Picci, P., Triche, T., Horvai, A. E., Miettinen, M., Wei, J. S., Catchpool, D., Llombart-Bosch, A., Waldman, T., & Khan, J.
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-07-10
- Volume
- 10
- Issue
- 7
- Pages
- e1004475
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- OpenAlex
- W2044351445
- Cited by
- 435
- References
- 59
- FWCI
- 27.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.